Brent Kirk

Sr Director, Sales Strategy & Operations @BillionToOne

San Francisco, CA, US

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules using Next-Generation Sequencing. UNITY, our first commercial product, is the only test to screen mother and baby for Cystic Fibrosis, Spinal Muscular Atrophy, Sickle Cell Anemia, and alpha and beta Thallasemias at just 10 weeks into pregnancy. ACOG recommends these conditions be screened for all pregnancies.